Evaluasi Biologis Radiofarmaka 175yb-EDTMP

@inproceedings{Tulang2014EvaluasiBR,
  title={Evaluasi Biologis Radiofarmaka 175yb-EDTMP},
  author={Untuk Terapi Paliatif Pada Tulang and Rizky Juwita Sugiharti},
  year={2014}
}
BIOLOGICAL EVALUTION OF Yb-EDTMP AS RADIOPHARMACEUTICAL FOR BONE PAIN PALLIATION. Ideal radiopharmaceutical used as bone pain palliatives requires a moderate energy β emitter with a stable carrier molecule. Ytterbium-175 (T1/2 = 4.2 d, Eβ(max) = 0,480 MeV) has radionuclide properties suitable for palliative therapy of bone metastases. Ethylenediaminetetramethylene phosphonic acid (EDTMP) is known to form complexes with high stability. The present study was conducted to evaluate EDTMP complexed… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 10 REFERENCES

Karakteristik fisiko-kimia senyawa bertanda 175Yb-EDTMP

  • A Aziz, Marlina, MB Febrian
  • JSTNI ;
  • 2010

Penandaan ligan etilendiamin tetrametilen fosfonat (EDTMP) dengan radionuklida175Y

  • A. Aziz
  • JSTNI
  • 2009

Rhemium-186monoamine monoamid edithiolconjugated bisphosphonate derivates for bone pain palliation

  • K Ogawa, T Mukai, Y Arano, A Otaka, M Ueda, T Uehara
  • Nucl Med Biol
  • 2006

177LuDOTMP, 153Sm-DOTMP, 175Yb-EDTMP and Re-CTMP : Novel agents for bone pain palliation and their comparison with 153Sm-EDTMP

  • S Banerjee, S Chakraborty, T Das, K Kothari, G Samuel, MRA. Pillai
  • Founder’s Day Special Issue
  • 2005

Similar Papers

Loading similar papers…